BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19797538)

  • 1. Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases.
    Italia KY; Jijina FF; Chandrakala S; Nadkarni AH; Sawant P; Ghosh K; Colah RB
    J Clin Pharmacol; 2010 Feb; 50(2):231-4. PubMed ID: 19797538
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyurea for the treatment of sickle cell anemia.
    Platt OS
    N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxyurea and new agents for the treatment of sickle cell disease.
    Rodgers GP
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
    [No Abstract]   [Full Text] [Related]  

  • 4. Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia.
    Ballas SK; McCarthy WF; Guo N; DeCastro L; Bellevue R; Barton BA; Waclawiw MA;
    J Natl Med Assoc; 2009 Oct; 101(10):1046-51. PubMed ID: 19860305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic modulation of fetal hemoglobin.
    Steinberg MH; Rodgers GP
    Medicine (Baltimore); 2001 Sep; 80(5):328-44. PubMed ID: 11552087
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.
    Adekile A; Menzel S; Gupta R; Al-Sharida S; Farag A; Haider M; Akbulut N; Mustafa N; Thein SL
    Am J Hematol; 2015 Jul; 90(7):E138-9. PubMed ID: 25851995
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A; Gumruk F; Gurgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual consult--pregnant woman with sickle-cell disease.
    Borhan S
    Medscape Womens Health; 1999; 4(1):6. PubMed ID: 10089559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hydroxyurea in sickle cell disease.
    Halsey C; Roberts IA
    Br J Haematol; 2003 Jan; 120(2):177-86. PubMed ID: 12542474
    [No Abstract]   [Full Text] [Related]  

  • 14. Sickle cell patients find a brand New World.
    Noonan SS
    N J Med; 1999 Aug; 96(8):23-5. PubMed ID: 10457727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study.
    Wang WC; Helms RW; Lynn HS; Redding-Lallinger R; Gee BE; Ohene-Frempong K; Smith-Whitley K; Waclawiw MA; Vichinsky EP; Styles LA; Ware RE; Kinney TR
    J Pediatr; 2002 Feb; 140(2):225-9. PubMed ID: 11865275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
    Powars DR
    J Pediatr; 2001 Dec; 139(6):763-4. PubMed ID: 11743496
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
    Lemonne N; Charlot K; Waltz X; Ballas SK; Lamarre Y; Lee K; Hierso R; Connes C; Etienne-Julan M; Romana M; Connes P
    Haematologica; 2015 Oct; 100(10):e383-6. PubMed ID: 26137960
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of hemoglobinopathies found in Belgium].
    Fondu P
    Bull Mem Acad R Med Belg; 1995; 150(10-11):367-75; discussion 376-8. PubMed ID: 8845787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the use of hydroxyurea therapy in sickle cell disease.
    Wong TE; Brandow AM; Lim W; Lottenberg R
    Blood; 2014 Dec; 124(26):3850-7; quiz 4004. PubMed ID: 25287707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.